New imaging test for solid tumors
Part of Cancer clinical trials.
This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It could help diagnose cancer or check if it has returned after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been recently diagnosed with a solid tumor cancer, or doctors suspect you might have one, or you may have had cancer that came back after treatment.
- You are able to care for yourself (ECOG score 0 or 1).
- You are expected to live more than 6 months.
- If you can have children, you agree to use effective birth control for 6 months after the scan.
- You do not have any condition that makes it unsafe or impossible to have a PET scan, like being unable to lie still.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It is for people with certain types of cancer who are willing to have a biopsy of their tumor.
This study is testing a new type of PET scan that uses a special tracer to make tumors easier to see. It may help doctors get more accurate information about your tumor before you have a biopsy or surgery.
This trial is testing a new imaging agent called RT01-89Zr to see if it can help detect solid tumors during PET/CT scans. It involves an injection of the agent followed by imaging, and may offer a more targeted way to visualize tumors.
This trial tests a new type of PET scan (a special imaging test) called 89Zr-s-C1 to help detect and monitor solid tumors like melanoma, gastric cancer, or colorectal cancer. The scan may help doctors see tumors more clearly and track whether treatment is working.
This study tests whether a new imaging agent called 68Ga-MY6349 can help detect tumors during a PET/CT scan. If you are an adult with a solid tumor (newly diagnosed or already treated), you may be able to take part in this research to see if the new tracer works better than standard imaging.
This trial tests a special imaging technique that may help doctors see and stage solid tumors more precisely. It uses a targeted radioactive tracer to highlight cancer cells during PET and SPECT scans, which could help plan better treatment.
Hear when a new PET/CT trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.